Nicabate (Nicotine)

Nicotine, the active ingredient in Nicabate, is a nicotine replacement therapy presented as an oromucosal product for buccal administration. It is intended for adult smokers who wish to quit and works by reducing withdrawal symptoms and cravings associated with nicotine dependence. The product is marketed in the European Union and is available over the counter.

GNH USA supplies Nicabate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets.

Nicabate is a nicotine replacement therapy used in smoking cessation programs. - Smoking cessation: assists adult smokers in quitting by alleviating nicotine cravings. - Nicotine dependence: reduces withdrawal symptoms during the quitting process. - Relapse prevention: helps maintain abstinence after initial cessation.

Common side effects are generally mild and related to the route of administration.

Common Side Effects: - Mouth irritation: discomfort or soreness in the oral cavity. - Nausea: feeling of queasiness after use. - Hiccups: involuntary diaphragmatic contractions. - Dyspepsia: indigestion or stomach upset. - Headache: mild to moderate head pain. - Dizziness: transient light‑headed sensation.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Throat swelling: difficulty breathing or swallowing. - Chest pain: unexpected discomfort in the chest area. - Arrhythmia: irregular heart rhythm. - Severe skin rash: widespread erythema or blistering.

Before using Nicabate, consider the following safety measures. - Assess cardiovascular status: nicotine may increase heart rate and blood pressure. - Avoid use after recent myocardial infarction: nicotine can exacerbate ischemia. - Do not use in uncontrolled hypertension: monitor blood pressure closely. - Use with caution in pregnancy: limited data, discuss risks with a healthcare provider. - Avoid use in children and adolescents: not indicated for persons under 18. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicabate may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - CYP2A6 inhibitors: may raise nicotine plasma levels. - Concurrent nicotine products: risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine may reduce their antihypertensive effect. - Antidepressants (SSRIs): monitor for enhanced side effects. - Alcohol: may amplify nicotine's cardiovascular effects.